|
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (600196)3Q 2008 Net Profit: RMB 112.7 MlnAs of the end of 3Q 2008:Total assets: RMB 7,156,247,919 Shareholders' equity: RMB 3,930,834,956 Net asset value per share: RMB 3.18 1Q-3Q 2008: Net profit: RMB 609,024,624 Basic EPS: RMB 0.49 Basic EPS after deducting non-recurring gains and losses: RMB 0.25 Diluted return on equity: 15.49% Diluted return on equity after deducting non-recurring gains and losses: 7.83% Net cash flow per share arising from operating activities: RMB 0.08 3Q 2008: Net profit: RMB 112,794,658 Basic EPS: RMB 0.09 Diluted return on equity: 2.87% Diluted return on equity after deducting non-recurring gains and losses: 2.5% Board of Directors 27 Oct 2008 Source: Shanghai Stock Exchange Date: 28 Oct 2008 CN01/IS/LZ/NK/KM |
|
Copyright NewsnChina 2009 |